Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Richard E Champlin"'
Autor:
Curtis Marcoux, David Marin, Jeremy Ramdial, Gheath AlAtrash, Amin M. Alousi, Betul Oran, Partow Kebriaei, Uday R. Popat, Katayoun Rezvani, Richard E. Champlin, Elizabeth J. Shpall, Rohtesh S. Mehta
Publikováno v:
American Journal of Hematology. 98:712-719
Autor:
Partow Kebriaei, Julianne Chen, Demetrios Petropoulos, Muzaffar H. Qazilbash, Richard E. Champlin, Samer A. Srour, Jeremy Ramdial, Gabriela Rondon, Piyanuch Kongtim, Elizabeth J. Shpall, Uday R. Popat, Stefan O. Ciurea
Publikováno v:
American Journal of Hematology. 95:1187-1192
Relapse after allogeneic hematopoietic stem-cell transplantation (AHSCT) is associated with very poor outcomes. A second transplant offers the possibility of long-term disease control. We analyzed outcomes with haploidentical donors for second allogr
Autor:
Elizabeth S. Shpall, Ruby Delgado, Neeraj Saini, Rohtesh S. Mehta, Donna M. Weber, Krina K. Patel, Partow Kebriaei, Chitra Hosing, Muzaffar H. Qazilbash, Uday R. Popat, Amin M. Alousi, Richard E. Champlin, Robert Z. Orlowski, Sheeba K. Thomas, May Daher, Junsheng Ma, Gabriela Rondon, Qaiser Bashir, Yago Nieto, Samer A. Srour, Hans C. Lee, Romil Patel
Publikováno v:
American Journal of Hematology. 96
Autor:
Rohtesh S. Mehta, Bouthaina S. Dabaja, Richard E. Champlin, Madeleine Duvic, Courtney D. DiNardo, Katy Rezvani, Naval Daver, Carlos Antonio Torres Cabala, Elizabeth J. Shpall
Publikováno v:
American Journal of Hematology. 96
Autor:
Panupong Hansrivijit, Julianne Chen, Sharon R. Hymes, Uday R. Popat, Stefan O. Ciurea, Richard E. Champlin, Gabriela Rondon, Ana M. Ciurea, Chitra Hosing
Publikováno v:
American Journal of Hematology. 94:E176-E180
Autor:
Stefan O. Ciurea, Oran Betul, Julianne Chen, Maria C.B. Bittencourt, Richard E. Champlin, Samer A. Srour, Jeremy Ramdial, Gabriela Rondon, Partow Kebriaei, Uday R. Popat, Elizabeth J. Shpall, Qaiser Bashir, Piyanuch Kongtim, Amanda Olson, Issa F. Khouri
Publikováno v:
American Journal of Hematology. 95
Autor:
Partow Kebriaei, Jonathan E. Brammer, Sameh Gaballa, Rima M. Saliba, Michael Andreeff, Farhad Ravandi, Uday R. Popat, Jorge E. Cortes, Julianne Chen, Naval Daver, Stefan O. Ciurea, Gabriela Rondon, Amin M. Alousi, Keyur P. Patel, Elias Jabbour, David Marin, Richard E. Champlin, Betul Oran, Elizabeth J. Shpall, Borje S. Andersson
Publikováno v:
American Journal of Hematology. 92:331-337
In patients with AML with FMS-like tyrosine kinase 3 (FLT3) mutations, the significance of minimal residual disease (MRD) detected by PCR before allogeneic stem cell transplantation (SCT) on outcomes after transplant remains unclear. We identified 20
Autor:
Hans C. Lee, Partow Kebriaei, Romil Patel, Elisabet E. Manasanch, Chitra Hosing, Donna M. Weber, Gabriela Rondon, Ankur Varma, Sheeba K. Thomas, Robert Z. Orlowski, Qaiser Bashir, Krina K. Patel, Ruby Delgado, Yago Nieto, Neeraj Saini, Uday R. Popat, Muzaffar H. Qazilbash, Richard E. Champlin
Publikováno v:
American Journal of Hematology.
Autor:
Donna M. Weber, Sheeba K. Thomas, Elisabet E. Manasanch, Hans C. Lee, Krina K. Patel, Muzaffar H. Qazilbash, Gabriela Rondon, Yago Nieto, Partow Kebriaei, Ruby Delgado, Qaiser Bashir, Richard E. Champlin, Romil Patel, Amin M. Alousi, Sairah Ahmed, Neeraj Saini, Uday R. Popat, Chitra Hosing, Ankur Varma, Robert Z. Orlowski
Publikováno v:
American journal of hematology. 94(1)
Autor:
Betul Oran, Michael Andreeff, Tapan M. Kadia, Graciela M. Nogueras-Gonzalez, Guillermo Garcia Manero, William G. Wierda, Talha Badar, Farhad Ravandi, Keyur P. Patel, Gautam Borthakur, Raja Luthra, Richard E. Champlin, Marina Konopleva, Naval Daver, Hagop M. Kantarjian, Jorge E. Cortes
Publikováno v:
American Journal of Hematology. 90:1065-1070
AML with FLT3 ITD mutations are associated with poor outcome. We reviewed outcomes of patients with FLT3 ITD mutated AML to investigate trends over time. We analyzed 224 AML patients (excluding patients with core binding factor and acute promyelocyti